Cargando…

Severe Hypoglycemia and the Use of Glucagon Rescue Agents: An Observational Survey in Adults With Type 1 Diabetes

Severe hypoglycemia (SH) is the most frequent and potentially serious complication affecting individuals with type 1 diabetes and can have major clinical and psychosocial consequences. Glucagon is the only approved treatment for SH that can be administered by non–health care professionals (HCPs); ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hughes, Allyson S., Chapman, Katherine S., Nguyen, Huyen, Liu, Jingwen, Bispham, Jeoffrey, Winget, Melissa, Weinzimer, Stuart A., Wolf, Wendy A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2023
Materias:	Feature Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338275/ https://www.ncbi.nlm.nih.gov/pubmed/37456102 http://dx.doi.org/10.2337/cd22-0099

Ejemplares similares

“It’s embarrassing. I get angry. I get frustrated.”: Understanding severe hypoglycemia and glucagon usage from the perspectives of people with type 1 diabetes
por: Hughes, Allyson S., et al.
Publicado: (2022)

Use of Glucagon in Patients With Type 1 Diabetes
por: Haymond, Morey W., et al.
Publicado: (2019)

Development and validation of fear of hypoglycemia screener: results from the T1D exchange registry
por: Liu, Jingwen, et al.
Publicado: (2023)

Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey
por: Liu, Jingwen, et al.
Publicado: (2020)

“I Live in Constant Fear of Highs,” the Daily Impact of Type 1 Diabetes
por: Hughes, Allyson S, et al.
Publicado: (2020)

Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study
por: Yale, Jean-François, et al.
Publicado: (2017)

Lack of Association Between Residual Insulin Production and Glucagon Response to Hypoglycemia in Youth With Short Duration of Type 1 Diabetes
por: Sherr, Jennifer, et al.
Publicado: (2013)

Interventions to Improve Adherence to a Hypoglycemia Protocol
por: Destree, Lani, et al.
Publicado: (2017)

Using Shared Decision-Making to Address Possible Overtreatment in Patients at High Risk for Hypoglycemia: The Veterans Health Administration’s Choosing Wisely Hypoglycemia Safety Initiative
por: Wright, Samantha M., et al.
Publicado: (2018)

Prevalence of fear of hypoglycemia in adults with type 1 diabetes using a newly developed screener and clinician’s perspective on its implementation
por: Peter, Megan E, et al.
Publicado: (2023)

Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?
por: Aroda, Vanita R., et al.
Publicado: (2018)

Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation
por: Valentine, Virginia, et al.
Publicado: (2019)

Insulin Detemir Versus Insulin Glargine in the Hospital: Do Hypoglycemia Rates Differ?
por: Crisher, Michelle A., et al.
Publicado: (2019)

Emerging Adult and Caregiver Psychosocial Experiences with Severe Hypoglycemic Events and the Perceived Impact of Nasal Glucagon: A Cross-Sectional Study
por: Kelly, Caitlin S., et al.
Publicado: (2023)

Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia
por: Pontiroli, Antonio E., et al.
Publicado: (2019)

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
por: Hinnen, Deborah
Publicado: (2017)

Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to Know
por: Skolnik, Neil, et al.
Publicado: (2018)

A Comparative Study of Dasiglucagon Ready-to-Use Autoinjector and Glucagon Emergency Kit During Rescue from Simulated Severe Hypoglycemia
por: Bailey, Naila Celeste, et al.
Publicado: (2022)

Conversations and Reactions Around Severe Hypoglycemia (CRASH) Study: Results From People With Diabetes and Caregivers in the United States
por: Snoek, Frank J., et al.
Publicado: (2022)

Shadowing to Improve Teamwork and Communication:: A Potential Strategy for Surge Staffing
por: Sarver, Wendy L., et al.
Publicado: (2020)

A Quality Improvement Program to Reduce Potential Overtreatment of Diabetes Among Veterans at High Risk of Hypoglycemia
por: Vimalananda, Varsha G., et al.
Publicado: (2017)

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies
por: Shaefer, Charles F.
Publicado: (2016)

Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
por: Kedia, Nitil
Publicado: (2011)

Early Loss of the Glucagon Response to Hypoglycemia in Adolescents With Type 1 Diabetes
por: Siafarikas, Aris, et al.
Publicado: (2012)

Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model
por: Hinahara, Jordan, et al.
Publicado: (2022)

Are your IT staff ready for the pandemic-driven insider threat?
por: Chapman, Phil
Publicado: (2020)

Defending against insider threats with network security's eighth layer
por: Chapman, Phil
Publicado: (2021)

Use of glucagon in severe hypoglycemia is scarce in most countries, and has not been expanded by new ready-to-use glucagons
por: Pontiroli, Antonio E., et al.
Publicado: (2022)

A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia
por: Lobato, Carolina B., et al.
Publicado: (2020)

Managing Acute Seizures: New Rescue Delivery Option and Resources to Assist School Nurses
por: Dean, Patricia, et al.
Publicado: (2021)

Effect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial
por: Chaykin, Louis, et al.
Publicado: (2019)

Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study
por: Polonsky, William, et al.
Publicado: (2021)

Recruiting a dental nurse
por: Hughes, Joseph
Publicado: (2021)

Recruitment and Retention of Asian Americans in Web-Based Physical Activity Promotion Programs: A Discussion Paper
por: Chee, Wonshik, et al.
Publicado: (2019)

Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study
por: Bailey, Timothy S., et al.
Publicado: (2021)

Can antibiotic prescribing recover its downward trajectory during 2021?
por: Sanderson, Susie, et al.
Publicado: (2021)

A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia()
por: Chabenne, Joseph, et al.
Publicado: (2014)

Mitochondrial GTP Insensitivity Contributes to Hypoglycemia in Hyperinsulinemia Hyperammonemia by Inhibiting Glucagon Release
por: Kibbey, Richard G., et al.
Publicado: (2014)

Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
por: Ja’arah, Daria, et al.
Publicado: (2021)

Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
por: Osumili, Beatrice, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_25oce475mdce377gbv8ib240h1